"The Jeffersons" star Marla Gibbs reveals surviving a devastating brain aneurysm and stroke in 2006, sharing her inspiring ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...

Eli Lilly announced on " Good Morning America " Monday that its GLP-1 weight-loss drug Zepbound will now be available in a ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the treatment in a ...

Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

More than 1.6 million adults in ­England, Wales and Scotland used weight-loss drugs such as Wegovy and Mounjaro between early 2024 and early 2025.

You've seen plenty of weird engines on Jalopnik, from Trojan's weird two-stroke, four-cylinder cube with wishbone-shaped connecting rods to the Napier Deltic triangle-18 diesel, but never have you ...

After Novo Nordisk projected yesterday that its revenue could decline by as much as 13% in 2026, its share price has plummeted by 20%. Because the Danish company attributed much of the shortfall to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing company Seamless Therapeutics. This morning’s deal with Seamless centers on ...

Overall deaths from heart disease and stroke continuing to decline, with fewer deaths and improvement in age-adjusted death rate. (HealthDay News) — Heart disease and stroke combined account for more ...